Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red

Experimental Neurology

Volumn 177, Issue 1, 2002, Pages 88-94

  Sakamoto, Masaki ^a,b,c   Uchihara, Toshiki ^b   Hayashi, Masaharu ^b   Nakamura, Ayako ^b   Kikuchi, Etsuko ^b   Mizutani, Toshio ^a   Mizusawa, Hidehiro ^c   Hirai, Shunsaku ^a  

^a TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Alpha synuclein; Campbell Switzer method; CARD; Cingulate gyrus; Confocal laser microscope; Lewy body; Substantia nigra; Thiazin red; Triple labeling immunohistochemical study; Ubiquitin

Indexed keywords

ALPHA SYNUCLEIN; ANTIBODY; POLYCLONAL ANTIBODY; THIAZINE DERIVATIVE; UBIQUITIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; BRAIN; CELL HETEROGENEITY; CINGULATE GYRUS; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; MOLECULAR EVOLUTION; PARKINSON DISEASE; PRIORITY JOURNAL; STAINING; SUBSTANTIA NIGRA;

EID: 0036434291     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7961     Document Type: Article

References (45)

1. Galloway, P. G., P. Mulvihill, and G. Perry. 1992. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am. J. Pathol. 140: 809-822.
2. Wakabayashi, K., S. Hayashi, M. Yoshimoto, H. Kudo, and H. Takahashi. 2000. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol. (Berlin) 99: 14-20.
3. Gomez-Tortosa, E., K. Newell, M. C. Irizarry, J. L. Sanders, and B. T. Hyman. 2000. Alpha-synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining. Acta Neuropathol. (Berlin) 99: 352-357.
4. Gai, W. P., H. X. Yuan, X. Q. Li, J. T. Power, P. C. Blumbergs, and P. H. Jensen. 2000. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166: 324-333.
5. Hill, W. D., V. M. Lee, H. I. Hurtig, J. M. Murray, and J. Q. Trojanowski. 1991. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies. J. Comp. Neurol. 309: 150-160.
6. Bethlem, J., and W. A. D. H. Jager. 1960. The incidence and characteristic of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). J. Neurol. Neurosurg. Phychiatry 23: 74-80.
7. Forno, L. S., and R. L. Norville. 1976. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol. (Berlin) 34: 183-197.
8. Hainfellner, J. A., P. Pilz, H. Lassmann, G. Ladurner, and H. Budka. 1995. Diffuse Lewy body disease as substrate of primary lateral sclerosis. J. Neurol. 242: 59-63.
9. Masliah, E., D. Galasko, C. A. Wiley, and L. A. Hansen. 1990. Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia. Acta Neuropathol. (Berlin) 80: 453-458.
10. Forno, L. S. 1987. The Lewy body in Parkinson's disease. Adv Neurol. 45: 35-43.
11. Fukuda, T., J. Tanaka, K. Watabe, R. T. Numoto, and M. Minamitani. 1993. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain-stem in Lewy body disease. Acta Pathol. Jpn. 43: 545-551.
12. Pappolla, M. A., D. L. Shank, J. Alzofon, and A. W. Dudley. 1988. Colloid (hyaline) inclusion bodies in the central nervous system: Their presence in the substantia nigra is diagnostic of Parkinson's disease. Hum. Pathol. 19: 27-31.
13. Roy, S., and L. Wolman. 1969. Ultrastructural observations in Parkinsonism. J. Pathol. 99: 39-44.
14. Takahashi, H., K. Iwanaga, S. Egawa, and F. Ikuta. 1994. Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-Parkinsonian patient. Neuropathology 14: 73-80.
15. Dale, G. E., A. Probst, P. Luthert, J. Martin, B. H. Anderton, and P. N. Leigh. 1992. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol. (Berlin) 83: 525-529.
16. Wakabayashi, K., S. Hayashi, A. Kakita, M. Yamada, Y. Toyoshima, M. Yoshimoto, and H. Takahashi. 1998. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol. (Berlin) 96: 445-452.
17. Baba, M., S. Nakajo, P. H. Tu, T. Tomita, K. Nakaya, V. M. Lee, J. Q. Trojanowski, and T. Iwatsubo. 1998. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152: 879-884.
18. Trojanowski, J. Q., and V. M. Lee. 1998. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: Implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch. Neurol. 55: 151-152.
19. Conway, K. A., J. D. Harper, and P. T. Lansbury. 1998. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4: 1318-1320.
20. Crowther, R. A., R. Jakes, M. G. Spillantini, and M. Goedert. 1998. Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett. 436: 309-312.
21. Masliah, E., E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, and L. Mucke. 2000. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science 287: 1265-1269.
22. Feany, M. B., and W. W. Bender. 2000. A Drosophila model of Parkinson's disease. Nature 404: 394-398.
23. Goldberg, M. S., and P. T. Lansbury, Jr. 2000. Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nat. Cell Biol. 2: E115-119.
24. Engelender, S., Z. Kaminsky, X. Guo, A. H. Sharp, R. K. Amaravi, J. J. Kleiderlein, R. L. Margolis, J. C. Troncoso, A. A. Lanahan, P. F. Worley, V. L. Dawson, T. M. Dawson, and C. A. Ross. 1999. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. Nat. Genet. 22: 110-114.
25. Shimura, H., M. G. Schlossmacher, N. Hattori, M. P. Frosch, A. Trockenbacher, R. Schneider, Y. Mizuno, K. S. Kosik, and D. J. Selkoe. 2001. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease. Science 293: 263-269.
26. Chung, K. K., Y. Zhang, K. L. Lim, Y. Tanaka, H. Huang, J. Gao, C. A. Ross, V. L. Dawson, and T. M. Dawson. 2001. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: Implications for Lewy-body formation in Parkinson disease. Nat. Med. 7: 1144-1150.
27. Uchihara, T., A. Nakamura, M. Yamazaki, and O. Mori. 2000. Tau-positive neurons in corticobasal degeneration and Alzheimer's disease - Distinction by thiazin red and silver impregnations. Acta Neuropathol. (Berlin) 100: 385-389.
28. Uchihara, T., A. Nakamura, U. Nagaoka, M. Yamazaki, and O. Mori. 2000. Dual enhancement of double immunofluorescent signals by CARD: Participation of ubiquitin during formation of neurofibrillary tangles. Histochem. Cell Biol. 114: 447-451.
29. Sandmann-Keil, D., H. Braak, M. Okochi, C. Haass, and E. Braak. 1999. Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol. (Berlin) 98: 461-464.
30. McKeith, I. G., D. Galasko, K. Kosaka, E. K. Perry, D. W. Dickson, L. A. Hansen, D. P. Salmon, J. Lowe, S. S. Mirra, E. J. Byrne, G. Lennox, N. P. Quinn, J. A. Edwardson, P. G. Ince, C. Bergeron, A. Burns, B. L. Miller, S. Lovestone, D. Collerton, E. N. Jansen, C. Ballard, R. A. de Vos, G. K. Wilcock, K. A. Jellinger, and R. H. Perry. 1996. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47: 1113-1124.
31. Adams, J. C. 1992. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem. 40: 1457-1463.
32. Forno, L. S. 1996. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55: 259-272.
33. Paxinou, E., Q. Chen, M. Weisse, B. I. Giasson, E. H. Norris, S. M. Rueter, J. Q. Trojanowski, V. M. Lee, and H. Ischiropoulos. 2001. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21: 8053-8061.
34. Bence, N. F., R. M. Sampat, and R. R. Kopito. 2001. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555.
35. Okochi, M., J. Walter, A. Koyama, S. Nakajo, M. Baba, T. Iwatsubo, L. Meijer, P. J. Kahle, and C. Haass. 2000. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 275: 390-397.
36. Nakamura, T., H. Yamashita, T. Takahashi, and S. Nakamura. 2001. Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. Biochem. Biophys. Res. Commun. 280: 1085-1092.
37. Ellis, C. E., P. L. Schwartzberg, T. L. Grider, D. W. Fink, and R. L. Nussbaum. 2001. Alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J. Biol. Chem. 276: 3879-3884.
38. Giasson, B. I., J. E. Duda, I. V. Murray, Q. Chen, J. M. Souza, H. I. Hurtig, H. Ischiropoulos, J. Q. Trojanowski, and V. M. Lee. 2000. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989.
39. Souza, J. M., B. I. Giasson, Q. Chen, V. M. Lee, and H. Ischiropoulos. 2000. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275: 18344-18349.
40. Good, P. F., A. Hsu, P. Werner, D. P. Perl, and C. W. Olanow. 1998. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57: 338-342.
41. D'Andrea, M. R., S. Ilyin, and C. R. Plata-Salaman. 2001. Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues. Neurosci. Lett. 306: 137-140.
42. Iseki, E., W. Marui, H. Akiyama, K. Ueda, and K. Kosaka. 2000. Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry. Neurosci. Lett. 286: 69-73.
43. Togo, T., E. Iseki, W. Marui, H. Akiyama, K. Ueda, and K. Kosaka. 2001. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. J. Neurol. Sci. 184: 71-75.
44. Wakabayashi, K., S. Engelender, M. Yoshimoto, S. Tsuji, C. A. Ross, and H. Takahashi. 2000. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Ann. Neurol. 47: 521-523.
45. Shimura, H., N. Hattori, S. Kubo, Y. Mizuno, S. Asakawa, S. Minoshima, N. Shimizu, K. Iwai, T. Chiba, K. Tanaka, and T. Suzuki. 2000. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25: 302-305.